These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32467671)
21. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
22. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
25. Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer. Yuan L; Lu Z; Sun G; Cao D Medicine (Baltimore); 2022 Oct; 101(42):e31299. PubMed ID: 36281082 [TBL] [Abstract][Full Text] [Related]
26. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646 [No Abstract] [Full Text] [Related]
27. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer. Tong H; Li T; Gao S; Yin H; Cao H; He W Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830 [TBL] [Abstract][Full Text] [Related]
28. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
29. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer. Wu Z; Wen Z; Li Z; Yu M; Ye G Medicine (Baltimore); 2021 Jan; 100(3):e23836. PubMed ID: 33545950 [TBL] [Abstract][Full Text] [Related]
30. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival. Zhang D; Zheng Y; Yang S; Li Y; Wang M; Yao J; Deng Y; Li N; Wei B; Wu Y; Zhu Y; Li H; Dai Z Front Oncol; 2020; 10():596087. PubMed ID: 33489894 [TBL] [Abstract][Full Text] [Related]
31. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. Cui Y; Zhou Z; Chai Y; Che X; Zhang Y J Oncol; 2021; 2021():8533464. PubMed ID: 34484338 [TBL] [Abstract][Full Text] [Related]
32. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer. Li X; Fu S; Huang Y; Luan T; Wang H; Wang J BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038 [TBL] [Abstract][Full Text] [Related]
33. Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal Cancer. Zhu J; Wang S; Bai H; Wang K; Hao J; Zhang J; Li J Front Oncol; 2021; 11():588811. PubMed ID: 33747908 [TBL] [Abstract][Full Text] [Related]
34. Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma. Li T; Tong H; Zhu J; Qin Z; Yin S; Sun Y; Liu X; He W Front Med (Lausanne); 2021; 8():777507. PubMed ID: 35083240 [TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
37. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma. Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A Front Genet; 2021; 12():718717. PubMed ID: 34925438 [No Abstract] [Full Text] [Related]
38. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer. Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227 [TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y Front Genet; 2022; 13():787884. PubMed ID: 35350243 [No Abstract] [Full Text] [Related]
40. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]